Search

Your search keyword '"Periyasamy, Manikandan"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Periyasamy, Manikandan" Remove constraint Author: "Periyasamy, Manikandan"
127 results on '"Periyasamy, Manikandan"'

Search Results

4. Cytidine deaminases are regulators of estrogen receptor activity in breast cancer cells

5. Data from ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

6. Supplementary Figure S7. from ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

7. Supplementary Information from ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

8. Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion

9. Supplementary Table 1 from Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer

10. Supplementary Figures from Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer

11. Supplementary Figure Legends 1-6 from The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity

12. Supplementary Figures 1-6 from The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity

13. Data from The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity

14. Supplementary Tables 1-5 from The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity

15. Contributors

17. Mode-I Metal-Composite Interface Fracture Testing for Fibre Metal Laminates

18. Quasi-static indentation characteristics of sandwich composites with hybrid facesheets: Experimental and numerical approach

20. Enhancement Studies on Manufacturing and Properties of Novel Silica Aerogel Composites

21. Enhancement in Interply Toughness of BMI Composites Using Micro-Thin Films

22. Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth

26. Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB

27. VGLL1-directed TEAD activation drives endocrine therapy resistance in estrogen receptor positive breast cancer

28. Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer

29. Thermo-Mechanical Instability Characteristics of Laminated Composite Cylindrical Shells

31. A Numerical Study on High Velocity Impact Behavior of Titanium Based Fiber Metal Laminates

32. A similitude approach towards the understanding of low velocity impact characteristics of bi-layered hybrid composite structures

33. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells

34. Low velocity impact response of hybrid and fibre-metal composites

35. A layer-wise behavioral study of metal based interply hybrid composites under low velocity impact load

36. Antimicrobial potential and bioactive constituents from aerial parts of Vitis setosa Wall

37. Low velocity impact response of fibre-metal laminates – A review

38. ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

39. Estrogen receptor cistromics in breast tumors: from biomarkers to novel drug targets

40. Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-?B

41. Enhancement Studies on Manufacturing and Properties of Novel Silica Aerogel Composites

43. Impact face influence on low velocity impact performance of interply laminated plates

44. Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer

45. Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes

46. Cytidine Deaminases are Regulators of Estrogen Receptor Activity in Breast Cancer Cells

47. Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion

48. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer

50. Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer

Catalog

Books, media, physical & digital resources